The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy
Open accessAbstract
I focus on issues surrounding the promotion and marketing of controlled drugs and their regulatory oversight. Compared with noncontrolled drugs, controlled drugs, with their potential for abuse and diversion, pose different public health risks when they are overpromoted and highly prescribed. An in-depth analysis of the promotion and marketing of OxyContin illustrates some of the associated issues. Modifications of the promotion and marketing of controlled drugs by the pharmaceutical industry and an enhanced capacity of the Food and Drug Administration to regulate and monitor such promotion can have a positive impact on the public health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From the New York Times Magazine
Minsky, & Hyman, P. (1979) · Cited by 6,899
Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?
Wazana, A. (2000) · JAMA · doi:10.1001/jama.283.3.373 · Cited by 1,415
Regier, D. A. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210016003 · Cited by 1,256
Addiction Rare in Patients Treated with Narcotics
(1980) · New England Journal of Medicine · doi:10.1056/nejm198001103020221 · Cited by 1,106
Major increases in opioid analgesic abuse in the United States: Concerns and strategies
Compton, W. M., & Volkow, N. D. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.009 · Cited by 830
Martell, B. A., O'Connor, P. G., Kerns, R. D., Becker, W. C., Morales, K. H., Kosten, T. R., & Fiellin, D. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00006 · Cited by 774
Increasing deaths from opioid analgesics in the United States
Paulozzi, L. J., Budnitz, D. S., & Xi, Y. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1276 · Cited by 696
Efficacy of oxycodone in neuronathic pain: A randomized trial in postherpetic neuralgia
N. Watson, C. P., & Babul, N. (1998) · Neurology · doi:10.1212/wnl.50.6.1837 · Cited by 646
Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial
Raja, S. N., Haythornthwaite, J. A., Pappagallo, M., Clark, M. R., Travison, T. G., Sabeen, S., Royall, R. M., & Max, M. B. (2002) · Neurology · doi:10.1212/wnl.59.7.1015 · Cited by 593
Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain
Rowbotham, M. C., Twilling, L., Davies, P. S., Reisner, L., Taylor, K., & Mohr, D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021420 · Cited by 529
Cited by
Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis
Busse, J. W., Wang, L., Kamaleldin, M., Craigie, S., Riva, J. J., Montoya, L., Mulla, S. M., Lopes, L. C., Vogel, N., Chen, E., et al. (2018) · JAMA · doi:10.1001/jama.2018.18472 · Cited by 716
The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis
Ciccarone, D. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.01.010 · Cited by 677
Deyo, R. A., Von Korff, M., & Duhrkoop, D. (2015) · BMJ · doi:10.1136/bmj.g6380 · Cited by 507
“Every ‘Never’ I Ever Said Came True”: Transitions from opioid pills to heroin injecting
Mars, S. G., Bourgois, P., Karandinos, G., Montero, F., & Ciccarone, D. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.10.004 · Cited by 432
Humphreys, K., Shover, C. L., Andrews, C. M., Bohnert, A. S. B., Brandeau, M. L., Caulkins, J. P., Chen, J. H., Cuéllar, M.-F., Hurd, Y. L., Juurlink, D. N., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02252-2 · Cited by 421
Medical Marketing in the United States, 1997-2016
Schwartz, L. M., & Woloshin, S. (2019) · JAMA · doi:10.1001/jama.2018.19320 · Cited by 379
Alpert, A., Powell, D., & Pacula, R. L. (2018) · American Economic Journal: Economic Policy · doi:10.1257/pol.20170082 · Cited by 323
White opioids: Pharmaceutical race and the war on drugs that wasn’t
Netherland, J., & Hansen, H. (2017) · BioSocieties · doi:10.1057/biosoc.2015.46 · Cited by 314
US National Trends in Pediatric Deaths From Prescription and Illicit Opioids, 1999-2016
Gaither, J. R., Shabanova, V., & Leventhal, J. M. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.6558 · Cited by 314
The Opioid Epidemic: Crisis and Solutions
Skolnick, P. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052534 · Cited by 307
Geographic Variation in Opioid Prescribing in the U.S.
McDonald, D. C., Carlson, K., & Izrael, D. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2012.07.007 · Cited by 304
The prescription drug epidemic in the United States: A perfect storm
MAXWELL, J. C. (2011) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2011.00291.x · Cited by 275
Prescription drug overdoses: A review
Paulozzi, L. J. (2012) · Journal of Safety Research · doi:10.1016/j.jsr.2012.08.009 · Cited by 263
The Opioid Crisis: a Comprehensive Overview
Vadivelu, N., Kai, A. M., Kodumudi, V., Sramcik, J., & Kaye, A. D. (2018) · Current Pain and Headache Reports · doi:10.1007/s11916-018-0670-z · Cited by 258
Is the Prescription Opioid Epidemic a White Problem?
Hansen, H., & Netherland, J. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303483 · Cited by 207
Opioid-induced endocrinopathies
Fountas, A., Van Uum, S., & Karavitaki, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30254-2 · Cited by 77
Moral cleansing as hypocrisy: When private acts of charity make you feel better than you deserve.
O'Connor, K., Effron, D. A., & Lucas, B. J. (2020) · Journal of Personality and Social Psychology · doi:10.1037/pspa0000195 · Cited by 65
Noble, F., & Marie, N. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00742 · Cited by 56
Progress Stalled? The Uncertain Future of Mortality in High‐Income Countries
Dowd, J. B., Polizzi, A., & Tilstra, A. M. (2025) · Population and Development Review · doi:10.1111/padr.12687 · Cited by 21
Addiction, Thick Market Externalities, and the Persistence of the Opioid Epidemic
Cutler, D., & Donahoe, J. T. (2024) · doi:10.3386/w32055 · Cited by 13
Errors in Medicine: Punishment versus Learning Medical Adverse Events Revisited—Expanding the Frame
Brattebø, G., & Flaatten, H. K. (2023) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001235 · Cited by 12
On the early-life origins of vulnerability to opioid addiction
Levis, S. C., Bentzley, B. S., Molet, J., Bolton, J. L., Perrone, C. R., Baram, T. Z., & Mahler, S. V. (2019) · doi:10.1101/716522 · Cited by 3
Metadata
- Authors
- Van Zee, A.
- Venue
- American Journal of Public Health
- Publisher
- American Public Health Association
- Published
- 2009-02
- Volume
- 99
- Issue
- 2
- Pages
- 221-227
- ISSN
- 0090-0036 (ISSN-L)
- 1541-0048
- OpenAlex
- W2126791898
- Cited by
- 910
- References
- 45
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.